Finance

Lists
CLOV:NASDAQ
Clover Health Investments Corp
$4.56
-0.87%
(-0.040) 1D
$4.58
+0.33% (+0.015)
After hours
Closed: Oct 7, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLOV...
Open
$4.55
High
$4.75
Low
$4.53
Mkt. cap
2.42B
Avg. vol.
3.97M
Volume
7.41M
52-wk high
$5.59
52-wk low
$1.58
EPS
-$0.04
Beta
2.45
Shares outstanding
435.44M
No. of employees
724
Open
$4.55
High
$4.75
Low
$4.53
Mkt. cap
2.42B
Avg. vol.
3.97M
Volume
7.41M
52-wk high
$5.59
52-wk low
$1.58
EPS
-$0.04
Beta
2.45
Shares outstanding
435.44M
No. of employees
724
News stories
From web sources and news partners
Profile
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021. Wikipedia
About Clover Health Investments Corp
CEOAndrew Toy
Employees724
FoundedJul 17, 2014
HeadquartersJersey City, New Jersey, United States
SectorHealth care provider
Websitecloverhealth.com
Analyst ratings
Based on 3 analysts giving stock ratings to CLOV in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for CLOV in the last 3 months.
Highest
Current $4.56
$6.00 (+31.58%)
Average
$5.50 (+20.61%)
Lowest
$5.00 (+9.65%)
Analyst
Recommendation
Action
Price target
Projected
Date
George Hill
Deutsche Bank
Buy
Initiated
$6.00
+31.6%
09/11/2026
Richard Close
Canaccord Genuity
Buy
Maintained
$5.50
+20.6%
08/11/2026
Jonathan Yong
UBS
Hold
Maintained
$5.00
+9.6%
08/06/2026
Whit Mayo
Leerink Partners
Hold
Maintained
$3.00
-34.2%
10/22/2025
Last report
Aug 5, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.07 / $0.05
+48.00%beat
Revenue / Est. (USD)
743.17M / 732.67M
+1.43%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
495.85M
487.71M
749.19M
743.17M
Cost of goods sold
423.47M
413.50M
589.65M
590.16M
Cost of revenue
423.47M
413.50M
589.65M
590.16M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
97.15M
123.11M
131.69M
124.44M
Operating expense
96.75M
123.53M
132.21M
125.00M
Total operating expenses
520.23M
537.03M
721.86M
715.17M
Operating income
-24.38M
-49.32M
27.33M
28.00M
Other non operating income
-
-1.00K
-
-
EBT including unusual items
-24.38M
-49.32M
27.33M
28.00M
EBT excluding unusual items
-24.38M
-49.32M
27.33M
28.00M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-800.00K
-
-
-
Net income
-24.38M
-49.32M
27.33M
28.00M
Net profit margin
-4.92%
-10.11%
3.65%
3.77%
Earnings per share
0.00
-0.05
0.07
0.07
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
406.00K
420.00K
515.00K
564.00K
EBITDA
-23.97M
-48.90M
27.85M
28.56M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps